United States Antimony files $400 million common stock offering prospectus

Published 17/10/2025, 21:54
United States Antimony files $400 million common stock offering prospectus

United States Antimony Corporation (NYSE:UAMY) filed a prospectus supplement Friday under its automatic shelf registration statement, allowing for the offer and sale of up to $400 million in common stock. The filing was made pursuant to the company’s Amended and Restated Sales Agreement with A.G.P./Alliance Global Partners and B. Riley Securities, Inc., dated September 17, 2025.

The registration statement was filed with the Securities and Exchange Commission on Thursday and became effective immediately. The offering will be made only by means of the prospectus supplement referenced in the filing. The company’s common stock is registered on both the NYSE American and NYSE Texas exchanges under the ticker UAMY.

The opinion of Duane Morris LLP regarding the validity of the shares offered was included as an exhibit to the filing. No sales will occur in any state or jurisdiction where such an offer would be unlawful prior to registration or qualification under applicable securities laws. For deeper insights into UAMY’s valuation and growth prospects, access the comprehensive Pro Research Report available exclusively on InvestingPro, covering over 1,400 US stocks with expert analysis and actionable intelligence.

This information is based on a statement from the company’s SEC filing.

In other recent news, United States Antimony Corporation announced a $26.25 million direct offering of common stock. The company entered into a Securities Purchase Agreement to sell 3,500,000 shares at $7.50 per share to an institutional investor. The offering is expected to yield net proceeds of approximately $25,558,750 after expenses. Additionally, US Antimony has received its first $10 million order under a five-year, $245 million contract with the U.S. Defense Logistics Agency for supplying antimony metal ingots. This contract marks a significant collaboration with the Department of Defense. In response to these developments, H.C. Wainwright raised its price target for US Antimony to $8.50 from $4.50, maintaining a Buy rating. The contract with the Defense Logistics Agency has been highlighted as a pivotal achievement for the company.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.